As of September 30, 2019, a valuation allowance totaling $42.9 million has been established against our deferred tax assets.
During the three and nine months ended September 30, 2019, the Company incurred approximately $1.1 million and $1.9 million, respectively, related to these plans.
As a lessee, the adoption of this standard did not have a material impact on our Condensed Consolidated Statement of Income or Statement of Cash Flows.
These stock options were excluded because their exercise prices were greater than the average market price of the common shares, during the quarter, therefore making them anti-dilutive under the treasury stock method.
There are no legally binding leases that have not yet commenced.
All of the options above were issued at exercise prices that approximated fair market value at the date of grant.
Section 404 of the Sarbanes-Oxley Act of 2002 (“Section 404”) requires us to include in our annual reports on Form 10-K an assessment by the Company’s management of the effectiveness of our internal control over financial reporting.
For the three months ended September 30, 2018, 1.8 million stock options were outstanding but were not included in the computation of diluted earnings per share.
Prior to and after adoption, all of our leases in which we are the lessor were classified as sales-type leases.
This standard and related updates were effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years.See Note 4 of the Notes to Condensed Consolidated Financial Statements included in Part I, Item 1 of this report for additional information.
The following discussion should be read in conjunction with the consolidated financial statements and the related notes that appear in Part I, Item 1 of this document.
See also Item 1A, Risk Factors, of the 2018 Form 10‑K.
The stock options had exercise prices ranging from $15.33 to $16.97.
As a percentage of sales, selling, general and administrative expenses increased from 21.9% for the three months ended September 30, 2018 to 27.1% for the three months ended September 30, 2019, and decreased from 24.8% for the nine months ended September 30, 2018 to 24.1% for the nine months ended September 30, 2019.All non-functional currencies billed would result in a combined hypothetical gain or loss of $1.6 million if the U.S. dollar weakened or strengthened 10% against the billing currencies.Evaluation of Disclosure Controls and Procedures.The U.S. government has imposed tariffs on a wide-range of products and goods manufactured in China and imported into the U.S.